ConductScience.org, home

Paper8908703

Monoclonal antibodies in cancer therapy.

Gruber R and 2 others. Springer Semin Immunopathol, 1996. Cited by 11 papers, by iCite.

Cite this record

ConductScience Library. Monoclonal antibodies in cancer therapy. Papers, record 8908703. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8908703

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Monoclonal antibodies in cancer therapy.
PubMed
Journal
Springer Semin Immunopathol
PubMed
Year
1996
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
11
iCite
Relative citation ratio, by iCite
0.24
iCite
Revised in PubMed
2019-11-01
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Gruber RR
2Holz EE
3Riethmüller GG

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antibodies, MonoclonalMajor topic
NeoplasmsMajor topic
Animals
Humans
Neoplasms, Experimental

References51

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17671245Phase II trial of murine monoclonal antibody D612 combined with recombinant human monocyte colony-stimulating factor (rhM-CSF) in patients with metastatic gastrointestinal cancer.Cancer Res1995https://conductscience.org/library/papers/7671245PubMed
21498329Monoclonal antibody-based therapies of leukemia and lymphoma.Blood1992https://conductscience.org/library/papers/1498329PubMed
32529220Presence on a human melanoma of multiple antigens recognized by autologous CTL.Int J Cancer1989https://conductscience.org/library/papers/2529220PubMed
47627993Granulocyte/macrophage-colony-stimulating factor augments the induction of antibodies, especially anti-idiotypic antibodies, to therapeutic monoclonal antibodies.Cancer Immunol Immunother1995https://conductscience.org/library/papers/7627993PubMed
58621241Monoclonal anti-idiotypic antibody functionally mimics the human gastrointestinal carcinoma epitope GA733.Int J Cancer1996https://conductscience.org/library/papers/8621241PubMed
68397766Immunotoxins: magic bullets or misguided missiles?Immunol Today1993https://conductscience.org/library/papers/8397766PubMed
71925633The therapeutic use of monoclonal antibodies in colorectal carcinoma.Semin Oncol1991https://conductscience.org/library/papers/1925633PubMed
87585591Inhibition of tumor growth and metastasis by an immunoneutralizing monoclonal antibody to human vascular endothelial growth factor/vascular permeability factor121.Cancer Res1995https://conductscience.org/library/papers/7585591PubMed
98449598Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma--long-lasting, complete remissions can be induced.Int J Cancer1993https://conductscience.org/library/papers/8449598PubMed
108671606Monoclonal IgG as antigens: reduction is an early intracellular event of their processing by antigen-presenting cells.Int Immunol1996https://conductscience.org/library/papers/8671606PubMed
118478666Antibody localization in human renal cell carcinoma: a phase I study of monoclonal antibody G250.J Clin Oncol1993https://conductscience.org/library/papers/8478666PubMed
128622019Phase II study of weekly intravenous recombinant humanized anti-p185HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancer.J Clin Oncol1996https://conductscience.org/library/papers/8622019PubMed
137847642Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report.Ann Intern Med1995https://conductscience.org/library/papers/7847642PubMed
149815888Interleukin-2 enhancement of cytotoxicity by humanized monoclonal antibody M195 (anti-CD33) in myelogenous leukemia.Clin Cancer Res1995https://conductscience.org/library/papers/9815888PubMed
157868898
Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
J Immunol1995https://conductscience.org/library/papers/7868898PubMed
167662305Clinical issues in antibody design.Trends Biotechnol1995https://conductscience.org/library/papers/7662305PubMed
173721623The epithelial cell surface antigen 17-1A, a target for antibody-mediated tumor therapy: its biochemical nature, tissue distribution and recognition by different monoclonal antibodies.Int J Cancer1986https://conductscience.org/library/papers/3721623PubMed
187728746Tumor regression in monoclonal antibody-treated patients correlates with the presence of anti-idiotype-reactive T lymphocytes.Cancer Res1995https://conductscience.org/library/papers/7728746PubMed
192446326Micrometastatic cancer cells in bone marrow: in vitro detection with anti-cytokeratin and in vivo labeling with anti-17-1A monoclonal antibodies.Proc Natl Acad Sci U S A1987https://conductscience.org/library/papers/2446326PubMed
207882387Increased tumor cell reactivity and complement-dependent cytotoxicity with mixtures of monoclonal antibodies against different gangliosides.Cancer Immunol Immunother1995https://conductscience.org/library/papers/7882387PubMed

See all 51 referencesDownload CSV of references

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.

PMIDTitleJournalYearIn PapersSource
15726105Ascitic complement system in ovarian cancer.Br J Cancer2005https://conductscience.org/library/papers/15726105PubMed
15655555Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines.Br J Cancer2005https://conductscience.org/library/papers/15655555PubMed
12120821Therapeutic applications of monoclonal antibodies.Am J Med Sci2002https://conductscience.org/library/papers/12120821PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/8908703

GET https://conductscience.org/api/papers/v1/8908703/references?page=2